Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 5:05 AM
Ignite Modification Date:
2025-12-25 @ 5:05 AM
NCT ID:
NCT06518018
Eligibility Criteria:
Inclusion Criteria:
* Diagnosis of advanced Non-Small Cell Lung Cancer (NSCLC),Likely stage IIIB-IV, though specific staging is not mentioned
* Patients requiring second-line treatment Implying progression after first-line therapy
* Age: Adults (specific age range not provided, but typically 18 years or older)
* Presence of measurable disease according to RECIST v1.1 criteria
* Adequate organ function (specific parameters not provided, but typically included in such studies)
* Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 (not explicitly stated, but common in similar studies)
Exclusion Criteria:
* Presence of targetable driver mutations (e.g., EGFR, ALK, ROS1, BRAF)
* Prior treatment with HDR brachytherapy for the current disease
* Contraindications to immunotherapy or chemotherapy
* Severe comorbidities that would preclude safe administration of study treatments
* Brain metastases, unless treated and stable (not explicitly stated, but common in similar studies)
* Participation in another clinical trial with an investigational agent
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
90 Years
Study:
NCT06518018
Study Brief:
Protocol Section:
NCT06518018